Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation

Blood Cells, Molecules, and Diseases

Volumn 34, Issue 2, 2005, Pages 135-140

  Berliner, Shlomo ^a,b   Shapira, Itzhak ^a,b   Toker, Sharon ^a,b   Melamed, Samuel ^b,c   Shirom, Arie ^b   Rogowski, Ori ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Occupational Health and Rehabilitation Institute Israel   (Israel)

Author keywords

Benign hereditary leukopenia neutropenia; Microinflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ETHNIC GROUP; EUROPE; FEMALE; GENDER; GENETIC DISORDER; HEALTH PROGRAM; HUMAN; IMMIGRATION; ISCHEMIC HEART DISEASE; ISRAEL; JEW; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN SEA; METABOLIC SYNDROME X; MIDDLE EAST; NEUTROPENIA; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SCREENING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; YEMEN;

EID: 13844274911     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2004.11.004     Document Type: Article

References (22)

1. Y. Shoenfeld, M.L. Alkan, A. Asaly, Y. Carmeli, and M. Katz Benign familial leukopenia and neutropenia in different ethnic groups Eur. J. Haematol. 41 1988 273 277
2. Y. Shoenfeld, M. Modan, S. Berliner, V. Yair, M. Shaklai, A. Slusky, and J. Pinkhas The mechanism of benign hereditary neutropenia Arch. Intern. Med. 142 1982 797 799
3. Y. Shoenfeld, D. Aloni, G. Keren, M. Shaklai, M. Djaldetti, and J. Pinkhas Effect of physical effort on the white blood cells in benign familial leukopenia Acta Haematol. 65 1981 108 113
4. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
5. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
6. M. Haim, V. Boyko, U. Goldbourt, A. Battler, and S. Behar Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study Arch. Intern. Med. 164 2004 433 439
7. K. Ensrud, and H.R. Grimm The white blood cell count and risk for coronary heart disease Am. Heart J. 124 1992 207 212
8. S. Cohen, T. Tolshinsky, and O. Rogowski Real time, control adjusted evaluation of intensity of the inflammatory response J. Inf. Technol. Healthc. 1 2003 195 207
9. O. Rogowski, I. Shapira, A. Zimran, D. Zeltser, D. Elstein, D. Attias, A. Bashkin, and S. Berliner Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model Blood Cells, Mol. Dis. 34 2005 26 29
10. O. Rogowski, S. Toker, I. Shapira, S. Melamed, A. Shirom, D. Zeltser, and S. Berliner Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals Am. J. Cardiol. 95 2005 152 155
11. A. Clauss Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. Basel. 17 1957 237 246
12. N. Rifai, R.P. Tracy, and P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin. Chem. 45 1999 2136 2141
13. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
14. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
15. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 11 1999 448 454
16. P. Libby, and P.M. Ridker Inflammation and atherosclerosis: role of C-reactive protein in risk assessment Am. J. Med. 116 2004 9S 16S
17. P.M. Ridker On evolutionary biology, inflammation, infection, and the causes of atherosclerosis Circulation 105 2002 2 4
18. P.M. Ridker Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke Circulation 108 2003 e81 e85
19. J. Danesh, R. Collins, P. Appleby, and R. Peto Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1998 1477 1482
20. S.S. Anand, F. Razak, and Q. Yi C-reactive protein as a screening test for cardiovascular risk in a multiethnic population Arterioscler., Thromb., Vasc. Biol. 24 2004 1509 1515
21. M.A. Albert, and P.M. Ridker Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis Rev. Cardiovasc. Med. 5 Suppl. 3 2004 S22 S27
22. M.A. Albert, R.J. Glynn, J. Buring, and P.M. Ridker C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study) Am. J. Cardiol. 93 2004 1238 1242